Eli Lilly pharmaceuticals has announced a significant price reduction for the lowest dose of Zepbound, one of its high demand medications approved for weight loss. The announcement came Aug. 29 ...
You can’t become complacent with any stock, even one like EliLilly, which I think has the biggest pharmaceutical potential. I’ve mentioned it twice now, but it’s just on my mind.
The American pharmaceutical company EliLilly & Co. has entered into an agreement to acquire the biopharmaceutical company Morphic Holding Inc. This is reported in a press release EliLilly.